Full Text View
Tabular View
No Study Results Posted
Related Studies
Octreotide and Doxorubicin in Treating Patients With Advanced Cancer
This study is ongoing, but not recruiting participants.
Study NCT00008073   Information provided by National Cancer Institute (NCI)
First Received: January 6, 2001   Last Updated: July 25, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Interventions listed in this trial
doxorubicin hydrochloride
octreotide acetate
Additional drug interventions recognized in this trial
Doxorubicin
Octreotide
More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
UPMC Cancer Centers
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services